Amphastar Nanjing Pharmaceuticals Inc.

Amphastar Nanjing Pharmaceuticals Inc. is a high-tech pharmaceutical company that is engaged in research & development, production of pharmaceutical products including finished drugs and APIs. It is a holding company invested by Amphastar USA in February 2009. The company currently has a registered capital of $104.46 million, which covers such fields as pediatric, cardiovascular, endocrine, respiratory, anesthesia and other fields.